These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 30552564

  • 1. Five-year outcome of children with idiopathic nephrotic syndrome: the NEPHROVIR population-based cohort study.
    Dossier C, Delbet JD, Boyer O, Daoud P, Mesples B, Pellegrino B, See H, Benoist G, Chace A, Larakeb A, Hogan J, Deschênes G.
    Pediatr Nephrol; 2019 Apr; 34(4):671-678. PubMed ID: 30552564
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of mycophenolate mofetil or tacrolimus in children with steroid sensitive but frequently relapsing or steroid-dependent nephrotic syndrome.
    Wang J, Mao J, Chen J, Fu H, Shen H, Zhu X, Liu A, Shu Q, Du L.
    Nephrology (Carlton); 2016 Jan; 21(1):21-7. PubMed ID: 26697959
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab.
    Kamei K, Ogura M, Sato M, Sako M, Iijima K, Ito S.
    Pediatr Nephrol; 2016 Jan; 31(1):89-95. PubMed ID: 26341251
    [Abstract] [Full Text] [Related]

  • 4. Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.
    Harambat J, Godron A, Ernould S, Rigothier C, Llanas B, Leroy S.
    Pediatr Nephrol; 2013 Apr; 28(4):631-8. PubMed ID: 23179197
    [Abstract] [Full Text] [Related]

  • 5. Two-year outcome of the ISKDC regimen and frequent-relapsing risk in children with idiopathic nephrotic syndrome.
    Nakanishi K, Iijima K, Ishikura K, Hataya H, Nakazato H, Sasaki S, Honda M, Yoshikawa N, Japanese Study Group of Renal Disease in Children.
    Clin J Am Soc Nephrol; 2013 May; 8(5):756-62. PubMed ID: 23371961
    [Abstract] [Full Text] [Related]

  • 6. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
    Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T.
    Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800
    [Abstract] [Full Text] [Related]

  • 7. Treating the idiopathic nephrotic syndrome: are steroids the answer?
    Deschênes G, Dossier C, Hogan J.
    Pediatr Nephrol; 2019 May; 34(5):777-785. PubMed ID: 29869116
    [Abstract] [Full Text] [Related]

  • 8. [Idiopathic nephrotic syndrome in children: Incidence, clinical presentation, and outcome in the county of Gironde, France].
    Ernould S, Godron A, Nelson JR, Rigothier C, Llanas B, Harambat J.
    Arch Pediatr; 2011 May; 18(5):522-8. PubMed ID: 21458969
    [Abstract] [Full Text] [Related]

  • 9. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome.
    Inoki Y, Nishi K, Osaka K, Kaneda T, Akiyama M, Sato M, Ogura M, Kamei K.
    Pediatr Nephrol; 2024 Aug; 39(8):2393-2401. PubMed ID: 38267591
    [Abstract] [Full Text] [Related]

  • 10. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T, Sako M, Nakanishi K, Ishikura K, Ito S, Nakamura H, Oba MS, Nozu K, Iijima K.
    BMC Nephrol; 2018 Nov 01; 19(1):302. PubMed ID: 30382824
    [Abstract] [Full Text] [Related]

  • 11. [Childhood steroid-dependent idiopathic nephrotic syndrome: Predictive factors for the need of immunosuppressive treatment].
    Golay M, Douillard A, Nagot N, Fila M, Ichay L, Dalla Vale F, Tenenbaum J, Morin D.
    Arch Pediatr; 2017 Nov 01; 24(11):1096-1102. PubMed ID: 28941627
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome.
    Fujinaga S, Nishino T, Umeda C, Tomii Y, Watanabe Y, Sakuraya K.
    Pediatr Nephrol; 2019 Feb 01; 34(2):353-357. PubMed ID: 30426219
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcomes in idiopathic nephrotic syndrome: from childhood to adulthood.
    Skrzypczyk P, Panczyk-Tomaszewska M, Roszkowska-Blaim M, Wawer Z, Bienias B, Zajgzkowska M, Kilis-Pstrusinska K, Jakubowska A, Szczepaniak M, Pawlak-Bratkowska M, Tkaczyk M.
    Clin Nephrol; 2014 Mar 01; 81(3):166-73. PubMed ID: 24361057
    [Abstract] [Full Text] [Related]

  • 14. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases.
    Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F.
    Pediatr Nephrol; 2008 Aug 01; 23(8):1269-79. PubMed ID: 18465150
    [Abstract] [Full Text] [Related]

  • 15. Rituximab treatment for difficult-to-treat nephrotic syndrome in children: a multicenter, retrospective study.
    Taşdemir M, Canpolat N, Yıldız N, Özçelik G, Benzer M, Saygılı SK, Özkayin EN, Türkkan ÖN, Balat A, Candan C, Çelakıl M, Yavuz S, Akıncı N, Göknar N, Akgün C, Tülpar S, Alpay H, Sever FL, Bilge İ.
    Turk J Med Sci; 2021 Aug 30; 51(4):1781-1790. PubMed ID: 33581711
    [Abstract] [Full Text] [Related]

  • 16. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
    Zhonghua Er Ke Za Zhi; 2014 Mar 30; 52(3):194-200. PubMed ID: 24824389
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul 30; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 18. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome.
    Ravani P, Ponticelli A, Siciliano C, Fornoni A, Magnasco A, Sica F, Bodria M, Caridi G, Wei C, Belingheri M, Ghio L, Merscher-Gomez S, Edefonti A, Pasini A, Montini G, Murtas C, Wang X, Muruve D, Vaglio A, Martorana D, Pani A, Scolari F, Reiser J, Ghiggeri GM.
    Kidney Int; 2013 Nov 30; 84(5):1025-33. PubMed ID: 23739238
    [Abstract] [Full Text] [Related]

  • 19. Childhood idiopathic steroid resistant nephrotic syndrome in Southwestern Nigeria.
    Olowu WA, Adelusola KA, Adefehinti O.
    Saudi J Kidney Dis Transpl; 2010 Sep 30; 21(5):979-90. PubMed ID: 20814150
    [Abstract] [Full Text] [Related]

  • 20. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome.
    Gulati S, Pokhariyal S, Sharma RK, Elhence R, Kher V, Pandey CM, Gupta A.
    Nephrol Dial Transplant; 2001 Oct 30; 16(10):2013-7. PubMed ID: 11572890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.